Anti-inflammatory effect of lanoconazole on 12-O-tetradecanoylphorbol-13-acetate- and 2,4,6-trinitrophenyl chloride-induced skin inflammation in mice
© 2019 Blackwell Verlag GmbH..
BACKGROUND: Lanoconazole (LCZ) is a topical antifungal agent clinically used to treat fungal infections such as tinea pedis. LCZ has not only antifungal effects but also anti-inflammatory effects, which have the potential to provide additional clinical benefits. However, the characteristic features of the inhibitory effects of LCZ on skin inflammation remain unclear.
OBJECTIVE: We evaluated the inhibitory effects of topical application of LCZ, and compared the effects of LCZ with those of other antifungal agents including liranaftate, terbinafine and amorolfine.
METHODS: Each antifungal agent was topically applied on 12-O-tetradecanoylphorbol-13-acetate-induced irritant dermatitis and 2,4,6-trinitrophenyl chloride-induced contact dermatitis in mice (BALB/c). The ear thickness, myeloperoxidase activity and inflammatory mediator contents were evaluated.
RESULTS: LCZ dose-dependently suppressed 12-O-tetradecanoylphorbol-13-acetate-induced irritant dermatitis, suppressed the production of neutrophil chemotactic factors such as keratinocyte-derived chemokine and macrophage inflammatory protein-2, and inhibited neutrophil infiltration to the inflammation site. Moreover, 1% LCZ reduced the ear swelling in mice with 2,4,6-trinitrophenyl chloride-induced contact dermatitis in accordance with the inhibition of interferon-γ production. The inhibitory potency of LCZ on these types of dermatitis in mice was stronger than that of other types of antifungal agents.
CONCLUSION: The anti-inflammatory effects of LCZ were exerted through the inhibition of inflammatory mediator production. These effects may contribute to the relief of dermatitis symptoms in patients with tinea pedis.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:63 |
---|---|
Enthalten in: |
Mycoses - 63(2020), 2 vom: 09. Feb., Seite 189-196 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Nakamura, Aki [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 31.08.2020 Date Revised 10.01.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/myc.13034 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM303276479 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM303276479 | ||
003 | DE-627 | ||
005 | 20231225112501.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/myc.13034 |2 doi | |
028 | 5 | 2 | |a pubmed24n1010.xml |
035 | |a (DE-627)NLM303276479 | ||
035 | |a (NLM)31724251 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Nakamura, Aki |e verfasserin |4 aut | |
245 | 1 | 0 | |a Anti-inflammatory effect of lanoconazole on 12-O-tetradecanoylphorbol-13-acetate- and 2,4,6-trinitrophenyl chloride-induced skin inflammation in mice |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 31.08.2020 | ||
500 | |a Date Revised 10.01.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2019 Blackwell Verlag GmbH. | ||
520 | |a BACKGROUND: Lanoconazole (LCZ) is a topical antifungal agent clinically used to treat fungal infections such as tinea pedis. LCZ has not only antifungal effects but also anti-inflammatory effects, which have the potential to provide additional clinical benefits. However, the characteristic features of the inhibitory effects of LCZ on skin inflammation remain unclear | ||
520 | |a OBJECTIVE: We evaluated the inhibitory effects of topical application of LCZ, and compared the effects of LCZ with those of other antifungal agents including liranaftate, terbinafine and amorolfine | ||
520 | |a METHODS: Each antifungal agent was topically applied on 12-O-tetradecanoylphorbol-13-acetate-induced irritant dermatitis and 2,4,6-trinitrophenyl chloride-induced contact dermatitis in mice (BALB/c). The ear thickness, myeloperoxidase activity and inflammatory mediator contents were evaluated | ||
520 | |a RESULTS: LCZ dose-dependently suppressed 12-O-tetradecanoylphorbol-13-acetate-induced irritant dermatitis, suppressed the production of neutrophil chemotactic factors such as keratinocyte-derived chemokine and macrophage inflammatory protein-2, and inhibited neutrophil infiltration to the inflammation site. Moreover, 1% LCZ reduced the ear swelling in mice with 2,4,6-trinitrophenyl chloride-induced contact dermatitis in accordance with the inhibition of interferon-γ production. The inhibitory potency of LCZ on these types of dermatitis in mice was stronger than that of other types of antifungal agents | ||
520 | |a CONCLUSION: The anti-inflammatory effects of LCZ were exerted through the inhibition of inflammatory mediator production. These effects may contribute to the relief of dermatitis symptoms in patients with tinea pedis | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a CXC | |
650 | 4 | |a anti-inflammatory agents | |
650 | 4 | |a antifungal agents | |
650 | 4 | |a chemokines | |
650 | 4 | |a dermatitis:contact | |
650 | 4 | |a dermatitis:irritant | |
650 | 4 | |a dermatomycoses | |
650 | 4 | |a lanoconazole | |
650 | 4 | |a pharmacology | |
650 | 7 | |a Anti-Inflammatory Agents, Non-Steroidal |2 NLM | |
650 | 7 | |a Antifungal Agents |2 NLM | |
650 | 7 | |a Imidazoles |2 NLM | |
650 | 7 | |a Picrates |2 NLM | |
650 | 7 | |a latoconazole |2 NLM | |
650 | 7 | |a 4E7858311F |2 NLM | |
650 | 7 | |a picric acid |2 NLM | |
650 | 7 | |a A49OS0F91S |2 NLM | |
650 | 7 | |a Tetradecanoylphorbol Acetate |2 NLM | |
650 | 7 | |a NI40JAQ945 |2 NLM | |
700 | 1 | |a Uratsuji, Hideya |e verfasserin |4 aut | |
700 | 1 | |a Yamada, Yoshihito |e verfasserin |4 aut | |
700 | 1 | |a Hashimoto, Kei |e verfasserin |4 aut | |
700 | 1 | |a Nozawa, Naoki |e verfasserin |4 aut | |
700 | 1 | |a Matsumoto, Tatsumi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Mycoses |d 1990 |g 63(2020), 2 vom: 09. Feb., Seite 189-196 |w (DE-627)NLM01265194X |x 1439-0507 |7 nnns |
773 | 1 | 8 | |g volume:63 |g year:2020 |g number:2 |g day:09 |g month:02 |g pages:189-196 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/myc.13034 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 63 |j 2020 |e 2 |b 09 |c 02 |h 189-196 |